Drug intelligence / Profile preview

LiveSpo KIDS

Development stage: Preclinical
Lead developer: LiveSpo Pharma
Modality: Live Biotherapeutic Products → Microbiome Therapeutics
Administration: Oral

Overview

LiveSpo KIDS is a spore probiotic dietary supplement developed by Anabio R&D and manufactured by LiveSpo Pharma Company Limited. It contains spore-forming probiotics, specifically Bacillus clausii, Bacillus subtilis, and Bacillus coagulans. It is designed to support the reduction of constipation, anorexia, and slow weight gain in children aged 24-60 months by improving gut health, modulating intestinal microbiota, and potentially influencing immune responses. The product holds a registration number 1537/2023/ĐKSP issued by the Food Safety Department of the Ministry of Health in Vietnam.

Brand names: LiveSpo KIDS

Beyond the preview

Go deeper on LiveSpo KIDS.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on LiveSpo KIDS.

Explore the full profile